base
upon
fact
lnucleosid
gener
known
less
cytotox
dcounterpart
lbicyclo
hexenyl
carbanucleosid
deriv
fix
north
conform
design
synthes
employ
novel
synthet
strategi
start
r
epichlorohydrin
order
search
new
antihiv
agent
high
potenc
less
cytotox
tandem
alkyl
clacton
chemoselect
reduct
ester
presenc
clacton
function
group
rcm
reaction
mitsunobu
coupl
reaction
use
key
reaction
dcounterpart
nucleosid
also
prepar
accord
synthet
method
among
synthes
carbanucleosid
dthymin
nucleosid
lthymin
nucleosid
exhibit
excel
activ
cell
higher
ddi
antiaid
drug
wherea
exhibit
high
cytotox
cell
line
show
discern
cytotox
cell
line
test
reflect
may
good
candid
antiaid
drug
also
show
weak
activ
without
cytotox
howev
none
synthes
nucleosid
exhibit
antivir
activ
rna
virus
includ
coxsaki
influenza
corona
polio
virus
mayb
due
dideoxi
structur
potent
antivir
effect
indic
nucleosid
belong
class
excel
candid
antidna
viru
agent
research
strongli
support
lnucleosid
class
promis
candid
antivir
agent
due
low
cytotox
good
antivir
activ
j
u
r
n
l
h
e
p
g
e
w
w
w
e
l
e
v
e
r
c
l
c
e
b
c
variou
enzym
associ
nucleosid
metabol
nucleotid
polymer
hand
number
lnucleosid
ftc
also
report
show
highli
potent
antihiv
activ
fig
lnucleosid
gener
known
less
cytotox
dcounterpart
bear
lock
north
conform
bond
singl
structur
synthes
antihiv
activ
compar
fig
although
less
potent
show
signific
antivir
activ
less
cytotox
vari
cell
type
stabl
condit
would
cleav
basi
find
part
ongo
effort
search
antivir
agent
better
potenc
less
cytotox
improv
stabil
interest
synthes
conform
northlock
enantiopur
dand
lbicyclo
hexenyl
carbanucleosid
deriv
involv
compar
antivir
activ
dcarbanucleosid
lcarbanucleosid
dand
lbicyclo
hexenyl
carbanucleosid
deriv
natur
nucleobas
prepar
use
r
epichlorohydrin
respect
start
materi
antivir
activ
coxsacki
evalu
new
strategi
synthesi
lbicyclo
hexenyl
carbanucleosid
analog
dcounterpart
success
accomplish
use
cyclopropan
via
tandem
alkyl
clacton
chemoselect
reduct
ester
year
sinc
initi
discoveri
acquir
immunodefici
syndrom
aid
caus
human
immunodefici
viru
hiv
diseas
grown
global
infecti
diseas
hiv
pathogen
retroviru
requir
revers
transcriptas
rt
copi
singlestrand
rna
genom
doublestrand
dna
copi
integr
host
cell
therefor
rt
aid
viru
import
candid
treatment
aid
search
effect
chemotherapeut
agent
hiv
infect
target
rt
initi
attempt
focus
develop
dideoxynucleosid
ddn
dideoxynucleosid
among
nucleosid
rt
inhibitor
nrti
deoxythymidin
azt
dideoxyinosin
ddi
dideoxycytidin
ddc
thiacytidin
wide
use
treat
aid
patient
fig
particularli
import
structur
characterist
presenc
doubl
bond
render
pseudosugar
ring
nearli
planar
highli
rigid
potent
nrti
abacavir
abc
fluorocytidin
also
doubl
bond
sugar
ring
respect
doubl
bond
consid
crucial
play
enhanc
antihiv
activ
fig
howev
oxanucleosid
belong
ddn
intrins
weak
glycosid
bond
unstabl
acid
condit
involv
gastric
environ
enzym
pyrimidin
purin
phosphorylas
spite
defect
ddn
deriv
promis
candid
aid
treatment
overcom
easi
cleavag
glycosid
bond
oxanucleosid
carbocycl
nucleosid
methylen
group
instead
ring
oxygen
atom
tetrahydrofuran
oxanucleosid
synthes
anticip
search
better
antivir
profil
lower
cytotox
improv
stabil
conform
rigid
methanocarba
mc
nucleosid
built
bicyclo
hexan
templat
south
e
north
n
e
conform
pseudorot
cycl
conform
normal
nucleosid
take
time
fig
nucleosid
bind
activ
site
enzym
conform
exhibit
differ
affin
therefor
rigid
mc
nucleosid
use
investig
conform
prefer
synthes
two
step
accord
procedur
report
tsuji
cowork
reaction
r
epichlorohydrin
diethyl
malon
sodium
metal
gave
cyclopropanefus
clacton
via
tandem
alkyl
follow
lacton
lacton
moieti
might
suscept
hydrolysi
ester
mayb
due
structur
constraint
caus
fuse
cyclopropan
ring
treatment
equiv
sodium
hydroxid
etoh
afford
monocarboxyl
sodium
salt
ester
select
reduc
sodium
borohydrid
reflux
recycl
back
clacton
acid
condit
protect
hydroxyl
group
tertbutyldiphenylsilyl
chlorid
produc
silyl
ether
reduc
dibalh
afford
correspond
lactol
yield
wittig
reaction
lactol
methyltriphenylphosphonium
bromid
presenc
potassium
tertbutoxid
afford
hydroxi
olefin
yield
quench
satur
aqueou
nh
cl
solut
howev
reaction
mixtur
partit
etoac
water
without
quench
satur
nh
cl
aqueou
solut
wittig
reaction
new
byproduct
appear
higher
r
f
valu
desir
compound
yield
turn
acetyl
compound
h
c
cosi
correl
spectroscopi
hmbc
heteronuclear
multipl
bond
correl
nmr
experi
acetyl
group
might
deriv
ethyl
acet
use
extract
due
basic
reaction
condit
swern
oxid
oxalyl
chlorid
dimethyl
sulfoxid
smoothli
proceed
produc
aldehyd
subject
grignard
reaction
vinylmagnesium
bromid
afford
allyl
alcohol
easili
separ
normal
silica
gel
column
chromatographi
stereochemistri
determin
correspond
bicyclo
hexenol
scaffold
form
via
rcm
ringclosur
metathesi
reaction
next
step
rcm
reaction
dien
second
gener
grubb
catalyst
produc
bicyclo
analog
respect
stereochemistri
confirm
compar
h
nmr
spectra
authent
enantiocounterpart
enantiom
prepar
chiral
bicyclo
hexan
templat
indic
rcm
product
deriv
compound
desir
stereochemistri
mitsunobu
reaction
nucleobas
yield
variou
conform
lock
nucleosid
also
potenti
start
materi
palladiummedi
coupl
reaction
nucleobas
produc
desir
banom
synthesi
uracil
thymin
lnucleosid
deriv
shown
scheme
condens
glycosyl
donor
bicyclo
hexenol
n
benzoyluracil
n
benzoylthymin
mitsunobu
condit
smoothli
proceed
give
protect
n
benzoyluracil
nucleosid
protect
n
benzoylthymin
nucleosid
respect
yield
final
deprotect
n
benzoyl
group
compound
ammonium
hydroxid
aqueou
solut
methanol
follow
desilyl
tbaf
ntetrabutylammonium
fluorid
gave
desir
uracil
thymin
lnucleosid
respect
yield
hand
correspond
cytosin
analog
synthes
start
uracil
nucleosid
analog
via
acetyl
free
hydroxyl
group
follow
success
three
convent
reaction
phosphoru
oxychlorid
pyridin
ii
ammonium
hydroxid
iii
methanol
ammonia
overal
yield
scheme
synthesi
adenin
lnucleosid
depict
scheme
mitsunobu
condit
coupl
gener
protect
nucleosid
yield
amin
methanol
ammonia
adenin
nucleosid
follow
desilyl
tbdp
group
tbaf
gave
final
adenin
lnucleosid
yield
synthesi
guanin
nucleosid
condens
mitsunobu
condit
afford
protect
nucleosid
scheme
subject
desilyl
tbaf
convers
nucleobas
guanin
n
naom
reflux
produc
guanin
lnucleosid
yield
mitsunobu
condens
gener
low
probabl
fix
conform
induc
fuse
cyclopropyl
group
doubl
bond
caus
backsid
attack
nucleobas
disfavor
case
lock
conform
increas
steric
hindranc
methinyl
hydrogen
methylen
group
nucleobas
expect
antivir
activ
final
conformationlock
dand
lcarbanucleosid
evalu
iiib
rod
coxsacki
virus
first
test
human
lymphocyt
cell
among
final
nucleosid
thymin
nucleosid
analog
show
potent
activ
ic
valu
lgml
lgml
respect
tabl
bigger
differ
two
strain
iiib
rod
activ
reflect
lnucleosid
might
fit
almost
equal
activ
site
two
strain
wherea
dnucleosid
might
fit
better
activ
site
iiib
strain
rod
strain
comparison
ic
valu
lgml
ddi
clinic
use
treatment
aid
patient
indic
thymin
nucleosid
exhibit
potent
activ
ddi
use
posit
control
although
antihiv
activ
exce
cc
lg
ml
less
cytotox
cc
lg
ml
correspond
fact
lnucleosid
gener
known
less
toxic
dcounterpart
select
index
cc
ec
toward
show
respect
respect
dideoxynucleosid
wherea
coxsaki
virus
polioviru
belong
rna
virus
point
might
result
lack
antivir
activ
coxsaki
virus
polioviru
antivir
evalu
conduct
lthymin
nucleosid
show
weak
activ
ic
lg
ml
without
discern
cytotox
antivir
inhibit
lthymin
nucleosid
also
perform
flua
influenza
viru
type
strain
taiwan
flua
strain
johannesburg
flub
influenza
viru
type
b
strain
panama
fcv
felin
coronaviru
strain
wsu
fip
felin
infecti
periton
viru
strain
wsu
neither
show
antivir
activ
cytotox
lg
ml
shown
mayb
influenza
corona
virus
virus
rna
genom
lnucleosid
show
cytotox
lg
ml
cell
line
test
accord
obtain
antivir
cytotox
result
dand
lbicyclo
hexenyl
carbanucleosid
synthes
exert
antivir
activ
dna
viru
aid
viru
requir
rnadepend
dna
polymer
process
lifecycl
lnucleosid
less
cytotox
dnucleosid
eg
vs
vs
order
search
new
antihiv
agent
high
potenc
less
cytotox
dand
lbicyclo
hexenyl
carbanucleosid
deriv
design
synthes
novel
synthet
strategi
start
r
epichlorohydrin
respect
tandem
alkyl
clacton
chemoselect
reduct
ester
presenc
clacton
function
group
grignard
reaction
rcm
reaction
mitsunobu
coupl
reaction
use
key
reaction
achiev
synthesi
north
conformationlock
dand
lcarbanucleosid
analog
synthes
bicycl
carbanucleosid
character
h
c
hmbc
hsqc
cosi
nmr
mass
uv
spectra
melt
point
optic
rotat
dthymin
nucleosid
lthymin
nucleosid
found
show
potent
activ
ddi
cell
wherea
exhibit
cytotox
cc
lg
ml
show
discern
cytotox
suggest
may
better
candid
develop
novel
antiaid
drug
also
found
exhibit
weak
activ
without
cytotox
addit
antivir
activ
rna
virus
coxsaki
virus
polioviru
test
compound
show
signific
antivir
activ
mayb
due
dideoxi
structur
compound
also
evalu
rna
virus
influenza
corona
virus
show
neither
antivir
activ
cytotox
interest
note
lnucleosid
show
cytotox
lg
ml
cell
test
probabl
low
cytotox
lnucleosid
may
close
associ
ltype
unnatur
type
potent
antivir
activ
dand
lthymin
carbanucleosid
indic
nucleosid
belong
class
excel
candid
antiaid
drug
antidna
viru
agent
research
strongli
support
lnucleosid
class
promis
candid
antivir
agent
due
low
cytotox
chemic
reagent
commerci
avail
melt
point
uncorrect
ultraviolet
uv
spectra
record
methylen
chlorid
meoh
jasco
uvvi
spectrophotomet
optic
rotat
measur
chloroform
meoh
dmf
jasco
digit
polarimet
nuclear
magnet
reson
nmr
data
record
bruker
ac
varian
uniti
inova
spectromet
varian
uniti
spectromet
use
cdcl
cd
od
chemic
shift
report
part
per
million
ppm
refer
respect
residu
solvent
deuter
peak
h
c
cd
od
h
c
cdcl
coupl
constant
report
hertz
abbrevi
use
follow
singlet
doublet
q
quartet
qd
quartet
doublet
multiplet
dd
doublet
doublet
br
broad
singlet
br
broad
doublet
reaction
describ
perform
nitrogen
argon
atmospher
monitor
thinlay
chromatographi
tlc
tlc
perform
merck
precoat
f
plate
column
chromatographi
perform
use
silica
gel
mesh
merck
anhydr
solvent
distil
cah
nabenzophenon
prior
use
solut
g
mmol
etoh
ml
treat
sodium
hydroxid
g
mmol
etoh
ml
stir
h
room
temperatur
reaction
mixtur
treat
sodium
borohydrid
g
mmol
reflux
h
cool
room
temperatur
n
hcl
ml
ad
slowli
etoh
reaction
mixtur
evapor
reduc
pressur
result
solut
ad
n
hci
ml
stir
h
room
temperatur
aqueou
layer
extract
methylen
chlorid
sever
time
organ
layer
dri
anhydr
mgso
filter
concentr
vacuo
residu
purifi
silica
gel
column
chromatographi
use
methylen
chlorid
meoh
eluent
give
lacton
g
colorless
oil
solut
g
mmol
imidazol
g
mmol
anhydr
methylen
chlorid
ml
ad
tertbutyldiphenylsilyl
chlorid
ml
mmol
dropwis
stir
room
temperatur
h
reaction
mixtur
extract
methylen
chlorid
organ
layer
dri
anhydr
mgso
filter
evapor
reduc
pressur
residu
purifi
silica
gel
column
chromatographi
use
hexan
ethyl
acet
eluent
give
silyl
ether
g
white
solid
mp
reaction
mixtur
stir
min
temperatur
meoh
ml
hexan
ml
ethyl
acet
ml
ad
success
result
mixtur
stir
overnight
allow
reach
room
temperatur
gener
gel
filter
pad
celit
filtrat
collect
concentr
reduc
pressur
residu
purifi
silica
gel
column
chromatographi
use
hexan
ethyl
acet
eluent
give
lactol
g
colorless
oil
stir
suspens
methyltriphenylphosphonium
bromid
g
mmol
anhydr
thf
ml
ad
potassium
tertbutoxid
g
mmol
mixtur
stir
room
temperatur
h
give
yellow
suspens
lactol
g
mmol
anhydr
thf
ml
ad
dropwis
reaction
mixtur
allow
reach
room
temperatur
stir
addit
h
treat
satur
aqueou
nh
cl
solut
ml
aqueou
layer
extract
methylen
chlorid
organ
layer
dri
anhydr
mgso
filter
evapor
vacuo
residu
purifi
silica
gel
column
chromatographi
use
hexan
ethyl
acet
eluent
give
hydroxyl
olefin
g
colorless
oil
stir
solut
oxalyl
chlorid
ml
mmol
anhydr
methylen
chlorid
ml
ad
dimethyl
sulfoxid
ml
mmol
anhydr
methylen
chlorid
ml
mixtur
stir
temperatur
min
mixtur
ad
solut
g
mmol
anhydr
methylen
chlorid
ml
reaction
mixtur
stir
h
addit
triethylamin
ml
mmol
mixtur
gradual
warm
room
temperatur
stir
h
reaction
mixtur
quench
satur
aqueou
nh
cl
solut
ml
extract
methylen
chlorid
combin
organ
layer
dri
anhydr
mgso
filter
concentr
reduc
pressur
residu
purifi
silica
gel
column
chromatographi
use
hexan
ethyl
acet
eluent
give
aldehyd
g
colorless
oil
stir
solut
g
mmol
anhydr
thf
ml
ad
dropwis
vinylmagnesium
bromid
ml
mmol
solut
thf
reaction
mixtur
stir
temperatur
h
mixtur
quench
satur
aqueou
nh
cl
solut
ml
mixtur
allow
warm
room
temperatur
extract
ether
organ
layer
dri
anhydr
mgso
filter
evapor
reduc
pressur
result
oil
purifi
silica
gel
column
chromatographi
use
hexan
ethyl
acet
eluent
give
allyl
alcohol
g
g
colorless
oil
respect
compound
stir
solut
g
mmol
anhydr
methylen
chlorid
ml
ad
grubb
catalyst
gener
mg
mmol
reaction
mixtur
stir
h
room
temperatur
volatil
remov
result
residu
purifi
column
chromatographi
use
hexan
ethyl
acet
eluent
give
bicyclo
stir
solut
mg
mmol
triphenyl
phosphin
mg
mmol
n
benzoyluracil
mg
mmol
anhydr
thf
ml
ad
dead
diethyl
azodicarboxyl
ml
mmol
dropwis
reaction
mixtur
stir
h
volatil
remov
vacuo
result
residu
purifi
silica
gel
column
chromatographi
use
hexan
ethyl
acet
eluent
give
n
benzoyluracil
nucleosid
mg
colorless
sticki
oil
uv
ch
cl
k
max
nm
lrm
fab
mz
mh
mna
hrm
fab
calcd
c
h
n
si
mh
found
stir
solut
tbdpsprotect
uracil
nucleosid
mg
mmol
thf
ml
ad
tbaf
ntetrabutylammonium
fluorid
ml
mmol
solut
thf
reaction
mixtur
stir
room
temperatur
h
reaction
mixtur
concentr
vacuo
result
residu
purifi
silica
gel
column
chromatographi
use
methylen
chlorid
meoh
eluent
give
final
uracil
nucleosid
mg
stir
solut
uracil
nucleosid
mg
mmol
anhydr
pyridin
ml
ad
acet
anhydrid
ml
mmol
room
temperatur
reaction
mixtur
stir
temperatur
overnight
reaction
mixtur
evapor
vacuo
partit
ethyl
acet
dilut
aqueou
hcl
solut
organ
layer
wash
satur
aqueou
nahco
solut
dri
anhydr
mgso
filter
evapor
reduc
pressur
result
residu
purifi
silica
gel
column
chromatographi
use
methylen
chlorid
meoh
eluent
give
acetyl
nucleosid
mg
sticki
oil
stir
suspens
acetyl
nucleosid
mg
mmol
mg
mmol
anhydr
pyridin
ml
ad
phosphoru
oxychlorid
ml
mmol
reaction
mixtur
stir
room
temperatur
overnight
water
ml
ad
slowli
reaction
mixtur
destroy
excess
phosphoru
oxychlorid
volatil
evapor
vacuo
ml
concentr
aqueou
ammonium
hydroxid
solut
ml
ad
reaction
mixtur
reaction
mixtur
stir
room
temperatur
overnight
volatil
evapor
reduc
pressur
methanol
ml
methanol
ammonia
ml
ad
result
residu
reaction
mixtur
stir
room
temperatur
overnight
volatil
remov
vacuo
result
residu
purifi
silica
gel
column
chromatographi
use
methylen
chlorid
meoh
eluent
give
final
cytosin
nucleosid
mg
light
brownish
solid
solut
triphenylphosphin
mg
mmol
anhydr
thf
ml
treat
dead
ml
mmol
dropwis
mixtur
stir
min
suspens
mg
mmol
n
benzoylthymin
mg
mmol
thf
ml
ad
reaction
mixtur
stir
h
volatil
remov
vacuo
result
residu
purifi
silica
gel
column
chromatographi
use
hexan
ethyl
acet
eluent
give
n
benzoylthymin
nucl
stir
solut
mg
mmol
triphenyl
phosphin
mg
mmol
mg
mmol
anhydr
thf
ml
ad
dead
ml
mmol
dropwis
reaction
mixtur
stir
h
volatil
remov
vacuo
result
residu
purifi
silica
gel
column
chromatographi
use
hexan
ethyl
acet
eluent
give
nucleosid
mg
colorless
sticki
oil
uv
ch
cl
k
max
nm
solut
mg
mmol
methanol
ammonia
ml
heat
glass
bomb
h
cool
room
temperatur
volatil
remov
vacuo
mixtur
filter
wash
methylen
chlorid
meoh
result
filtrat
evapor
reduc
pressur
result
residu
purifi
silica
gel
column
chromatographi
use
hexan
ethyl
acet
eluent
give
tbdpsprotect
adenin
nucleosid
mg
contamin
triphenylphosphin
oxid
colorless
sticki
oil
h
nmr
stir
solut
impur
tbdpsprotect
adenin
nucleosid
mg
mmol
thf
ml
ad
tbaf
ml
mmol
solut
thf
reaction
mixtur
stir
room
temperatur
h
reaction
mixtur
concentr
vacuo
result
residu
purifi
silica
gel
column
chromatographi
use
methylen
chlorid
meoh
eluent
give
final
adenin
nucleosid
mg
white
solid
mp
stir
suspens
mg
mmol
triphenyl
phosphin
mg
mmol
mg
mmol
anhydr
thf
ml
ad
dead
ml
mmol
dropwis
reaction
mixtur
stir
h
volatil
remov
vacuo
mixtur
filter
wash
methylen
chlorid
meoh
result
filtrat
evapor
reduc
pressur
result
residu
purifi
silica
gel
column
chromatographi
use
hexan
ethyl
acet
eluent
give
nucleosid
mg
contamin
triphenylphosphin
oxid
colorless
sticki
oil
h
nmr
synthesi
synthesi
accomplish
procedur
use
synthesi
spectral
data
ident
lnucleosid
except
valu
optic
rotat
reveal
valu
correspond
lnucleosid
opposit
sign
hivinfect
uninfect
cell
human
cell
line
carri
human
tlymphotrop
viru
type
obtain
pharmaceut
screen
center
korea
research
institut
chemic
technolog
korea
cell
line
medium
supplement
wv
fetal
bovin
serum
fb
gentamycin
lgml
mm
lglutamin
growth
medium
incub
humidifi
atmospher
contain
co
viabil
cell
investig
trypan
blue
dye
exclus
method
assay
cell
seed
densiti
cellswel
htlviiib
rod
use
antihiv
assay
obtain
cultur
supernat
cell
persist
infect
htlviiib
deriv
pool
american
patient
aid
harvest
cell
pellet
centrifug
supernat
contain
infecti
aliquot
store
refriger
deep
freezer
revoc
cell
cellsml
expos
cellfre
htlviiib
rod
dose
tcid
ml
tissu
cultur
infecti
dose
cultur
h
compound
test
compar
ddi
ddc
obtain
sigma
cytotox
abil
inhibit
hiv
replic
compound
first
dissolv
dmso
dilut
fb
use
maximum
final
concentr
dmso
ad
cell
cultur
highest
concentr
compound
determin
concentr
dmso
interfer
cell
growth
cytopath
effect
monitor
bromid
mtt
viabil
assay
micropl
test
well
compound
dilut
phosphatebuff
wv
sodium
chlorid
pb
alon
distribut
triplic
cell
adjust
cellsml
plate
well
rate
per
well
viru
suspens
ad
cell
without
drug
cultur
day
cytotox
mtt
assay
infect
cultur
carri
parallel
determin
cytotox
compound
briefli
cell
suspens
collect
mix
solut
mtt
mgml
pb
h
incub
supernat
remov
formazan
precipit
dissolv
n
hcl
absorb
nm
measur
multiwal
scan
spectrophotomet
enzymelink
immunosorb
assay
plate
reader
slt
percentag
toxic
defin
uninfect
untreat
control
cell
cytotox
concentr
cc
defin
concentr
requir
reduc
viabil
uninfect
cell
day
incub
presenc
compound
concentr
achiev
protect
concentr
requir
inhibit
hivinduc
destruct
cell
defin
inhibitori
concentr
ic
hivinfect
uninfect
cell
cellsml
target
cell
suspend
variou
concentr
sampl
cultur
day
co
incub
antiaid
activ
sampl
evalu
day
hiv
infect
